ReproCELL Balance Sheet Health
Financial Health criteria checks 6/6
ReproCELL has a total shareholder equity of ¥8.3B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥9.1B and ¥742.0M respectively.
Key information
0%
Debt to equity ratio
JP¥0
Debt
Interest coverage ratio | n/a |
Cash | JP¥6.57b |
Equity | JP¥8.31b |
Total liabilities | JP¥742.00m |
Total assets | JP¥9.05b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 4978's short term assets (¥7.4B) exceed its short term liabilities (¥678.0M).
Long Term Liabilities: 4978's short term assets (¥7.4B) exceed its long term liabilities (¥64.0M).
Debt to Equity History and Analysis
Debt Level: 4978 is debt free.
Reducing Debt: 4978 has no debt compared to 5 years ago when its debt to equity ratio was 1.1%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4978 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 4978 has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 19.3% each year